{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T03:25:34Z","timestamp":1789183534249,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:00:00Z","timestamp":1681862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Farmacia Hospitalaria"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.farma.2023.04.005","type":"journal-article","created":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T07:32:51Z","timestamp":1685172771000},"page":"218-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmaceutical care model in precision medicine in China"],"prefix":"10.1016","volume":"47","author":[{"given":"Ping","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liren","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baihong","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.farma.2023.04.005_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cger.2017.01.001","article-title":"Centers for medicare and medicaid services support for medication therapy management (enhanced medication therapy management): testing strategies for improving medication use among beneficiaries enrolled in medicare Part D","volume":"33","author":"Brandt","year":"2017","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"10.1016\/j.farma.2023.04.005_bb0010","first-page":"188","article-title":"Therapeutic drug monitoring (TDM) of phenytoin","volume":"66","author":"Wu","year":"1986","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.farma.2023.04.005_bb0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cll.2016.05.002","article-title":"Pharmacogenetics in oral antithrombotic therapy","volume":"36","author":"Maier","year":"2016","journal-title":"Clin Lab Med"},{"issue":"3","key":"10.1016\/j.farma.2023.04.005_bb0020","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.farma.2023.04.005_bb0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002160","article-title":"Pregnancy-associated changes in pharmacokinetics: a systematic review","volume":"13","author":"Pariente","year":"2016","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.farma.2023.04.005_bb0030","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s40262-019-00813-w","article-title":"Pharmacokinetics and target attainment of antibiotics in critically ill children: a systematic review of current literature","volume":"59","author":"Hartman","year":"2020","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"10.1016\/j.farma.2023.04.005_bb0035","first-page":"1","article-title":"Tissue penetration of antimicrobials in intensive care unit patients: a systematic review-part I","volume":"11","author":"Finazzi","year":"2022","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.farma.2023.04.005_bb0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/phar.2481","article-title":"Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management","volume":"41","author":"Pilch","year":"2021","journal-title":"Pharmacotherapy."},{"issue":"1","key":"10.1016\/j.farma.2023.04.005_bb0045","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.sapharm.2020.04.001","article-title":"Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic","volume":"17","author":"Ying","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.farma.2023.04.005_bb0050","doi-asserted-by":"crossref","first-page":"13641","DOI":"10.1038\/s41598-021-92909-2","article-title":"Positive evidence for clinical pharmacist interventions during interdisciplinary rounding at a psychiatric hospital","volume":"11","author":"Stuhec","year":"2021","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.farma.2023.04.005_bb0055","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2014.58.7550","article-title":"Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer","volume":"33","author":"Nightingale","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.farma.2023.04.005_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2023.104965","article-title":"Clinical pharmacists' reported approaches and processes for undertaking Home Medicines Review services: a national survey","volume":"109","author":"Lee","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"issue":"23","key":"10.1016\/j.farma.2023.04.005_bb0065","first-page":"3169","article-title":"Medical institution pharmaceutical service practices:general rule (in Chinese)","volume":"30","author":"Lu","year":"2019","journal-title":"China Pharmacy"},{"issue":"1","key":"10.1016\/j.farma.2023.04.005_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cpt.2387","article-title":"Pharmacogenomic Clinical Decision Support: A Review, How-to Guide, and Future Vision","volume":"112","author":"Wake","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 4","key":"10.1016\/j.farma.2023.04.005_bb0075","doi-asserted-by":"crossref","first-page":"S363","DOI":"10.1093\/cid\/ciaa1536","article-title":"Evidence-based Guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring","volume":"71","author":"He","year":"2020","journal-title":"Chinese Pharmacol Soc Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.farma.2023.04.005_bb0080","first-page":"897","article-title":"The expert consensus on the standards of therapeutic drug monitoring (2019 Edition) (in Chinese)","volume":"19","author":"Zhang","year":"2019","journal-title":"Eval Anal Drug-use Hosp Chin"},{"issue":"17","key":"10.1016\/j.farma.2023.04.005_bb0085","first-page":"1443","article-title":"Division of therapeutic drug monitoring, Chinese pharmacological society. expert consensus on quality assurance of chromatographic technology for therapeutic drug monitoring (2021 Edition) (in Chinese)","volume":"56","author":"Miao","year":"2021","journal-title":"Chin Pharm J"},{"key":"10.1016\/j.farma.2023.04.005_bb0090","article-title":"Creating China's Biosimilar Drugs Regulatory System: A Calculated Approach","volume":"13","author":"Yang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.farma.2023.04.005_bb0095","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.mayocp.2020.03.011","article-title":"Considerations When Applying Pharmacogenomics to Your Practice","volume":"96","author":"Nicholson","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.farma.2023.04.005_bb0100","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/cpt.2754","article-title":"Cost Effectiveness of Pharmacogenetic Testing for Drugs with Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines: A Systematic Review","volume":"112","author":"Morris","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.farma.2023.04.005_bb0105","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00439-021-02282-3","article-title":"Current challenges and opportunities for pharmacogenomics: perspective of the Industry Pharmacogenomics Working Group (I-PWG)","volume":"141","author":"Bienfait","year":"2022","journal-title":"Hum Genet"},{"key":"10.1016\/j.farma.2023.04.005_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.693453","article-title":"Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice","volume":"12","author":"Tafazoli","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.farma.2023.04.005_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41576-022-00572-8","article-title":"Pharmacogenomics: current status and future perspectives","author":"Pirmohamed","year":"2023","journal-title":"Nat Rev Genet"},{"issue":"6","key":"10.1016\/j.farma.2023.04.005_bb0120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/17512433.2021.1911642","article-title":"Prediction of vancomycin dose on high-dimensional data using machine learning techniques","volume":"14","author":"Huang","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.farma.2023.04.005_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104242","article-title":"An ensemble learning based framework to estimate warfarin maintenance dose with cross-over variables exploration on incomplete data set","volume":"131","author":"Liu","year":"2021","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.farma.2023.04.005_bb0130","article-title":"Predicting Lapatinib Dose Regimen Using Machine Learning and Deep Learning Techniques Based on a Real-World Study","volume":"12","author":"Yu","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.farma.2023.04.005_bb0135","article-title":"A prediction model for tacrolimus daily dose in kidney transplant recipients with machine learning and deep learning techniques","volume":"9","author":"Zhang","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"10.1016\/j.farma.2023.04.005_bb0140","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3945\/ajcn.116.143131","article-title":"Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT)","volume":"105","author":"Qin","year":"2017","journal-title":"Am J Clin Nutr"},{"issue":"13","key":"10.1016\/j.farma.2023.04.005_bb0145","first-page":"1545","article-title":"Polypharmacy management in elderly patients with multimorbidity (in Chinese)","volume":"25","author":"Pan","year":"2022","journal-title":"Chinese General Pract"},{"issue":"05","key":"10.1016\/j.farma.2023.04.005_bb0150","article-title":"Chinese Pharmacological Society;China-Japan Friendship Hospital, interpretation of consensus of pharmaceutical experts on drug monitoring of anti-tumor biosimilars (2020 Edition)","volume":"20","author":"Zhang","year":"2020","journal-title":"Evaluat Analys Drug-Use Hospitals"},{"issue":"13","key":"10.1016\/j.farma.2023.04.005_bb0155","first-page":"1088","article-title":"Pharmacokinetics of busulfan in patients of children and adults prior to hematopoietic stem cell transplantation (in Chinese)","volume":"48","author":"Zheng","year":"2013","journal-title":"Chin Pharm J"},{"issue":"8","key":"10.1016\/j.farma.2023.04.005_bb0160","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5414\/CP203547","article-title":"Subacute stent thrombosis in a patient with type 2 diabetes and clopidogrel resistance: a case report","volume":"58","author":"Zhou","year":"2020","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Farmacia Hospitalaria"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634323000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1130634323000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T04:18:14Z","timestamp":1761106694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1130634323000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1130634323000405"],"URL":"https:\/\/doi.org\/10.1016\/j.farma.2023.04.005","relation":{},"ISSN":["1130-6343"],"issn-type":[{"value":"1130-6343","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmaceutical care model in precision medicine in China","name":"articletitle","label":"Article Title"},{"value":"Farmacia Hospitalaria","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.farma.2023.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Farmacia Hospitalaria (S.E.F.H). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}